Idera Pharmaceuticals, Inc. · Cambridge, MA United States (NASDAQ: IDRA)
| 167 Sidney St. | Phone: 617-679-5500 |
| Cambridge, MA | Fax: 617-679-5592 |
| 02139 | |
| United States | 
Map This Company |
Idera Pharmaceuticals, Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Idera Pharmaceuticals is open to the idea of tinkering with your immune system. The biotech firm is developing DNA and RNA therapies that manipulate the immune system's response to disease. It is focused on Toll-Like Receptors (TLRs) -- immune cell receptors that recognize and respond to viral and bacterial invaders. Some of Idera's drugs (such as treatments for infectious disease and cancer) mimic those invaders to stimulate an immune response; others (including treatments for autoimmune and inflammatory diseases) target TLRs to suppress the immune response. The company's lead candidate is a potential treatment for hepatitis C. Idera conducts some of its R&D efforts through partnerships.
Idera Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: IDRA Single Location |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 26 |
Executives
24 executives listed for Idera Pharmaceuticals, Inc.'s Cambridge, MA location.
| Chairman, President, and CEO | Sudhir Agrawal | |
|---|---|---|
| Vice Chairman | Youssef El Zein | |
| SVP Operations, CFO, Treasurer, and Secretary | Louis Arcudi |